Complex Trials. De-risked.

Objective Endpoints

Behavioral science

AI-Ready EDC

The future of clinical trials depends on better data. Replior combines modern EDC, behavioral science-driven eCOA, and clinical-grade digital endpoints in one connected platform—helping sponsors and CROs reduce complexity, improve patient engagement, and capture more reliable clinical evidence.

Measure what
patients can't report

Sensor platform:
Scratch • Sleep • UV
What is next for your indication

What if dropout
wasn't your problem

Up to 99% retention Week 28.
eCOA/ePRO powered by behavioral science not reminders

Your protocol
is complex enough

EDC built in 10 days. Visual study design. Built by data managers, for data managers

Measure what
patients can't report

Sensor platform:
Scratch • Sleep • UV
What is next for your indication

What if dropout
wasn't your problem

Up to 99% retention Week 28.
eCOA/ePRO powered by behavioral science not reminders

Your protocol
is complex enough

EDC built in 10 days. Visual study design. Built by data managers, for data managers

Better Data. Better Decisions.

Replior is the only eClinical technology provider that combines a modern EDC, behavioral science-driven eCOA/ePRO, and clinical-grade wearable sensors in a single platform. Every solution is built on the same principles: evidence-based design, regulatory compliance from the ground up, and an uncompromising commitment to clinical data quality—from first patient in to database lock.

Replior EDC: A modern EDC built for your study

Traditional EDC systems force studies to fit the software. Replior EDC is built around your protocol, with a flexible, AI-ready architecture designed for modern clinical trials.

Replior eCOA/ePRO: Retain and Motivate Patients in Your Clinical Trials

Replior eCOA/ePRO goes beyond data capture. Built on behavioral science, it helps patients stay engaged, complete more assessments, and deliver higher-quality data.

Beyond Patient-Reported Outcomes

Patient diaries tell you how participants felt. Replior Digital Endpoints capture what actually happened—providing continuous, objective data that complements patient-reported outcomes

What's New

From objective UV data to 99% Week 28 retention.

In the Almirall AKtive Study, Replior’s UV sensor combined with Replior eCOA/ePRO to achieve 99% participant retention at Week 28, against a benchmark of roughly 80% across two prior comparable studies. Real-time UV exposure tracking and automated alerts kept participants compliant and engaged throughout the long-duration dermatology trial.

Integrated UV Monitoring

Real-time tracking of patient UV exposure, displayed directly in Replior eCOA/ePRO

Real-Time Alerts

Automated reminders keep patients within UV exposure limits.

99% Week 28 Retention

Behavioral science driven engagement design, combined with tailored messaging and adaptive video, delivered 99% retention at Week 28 in a long-duration dermatology study.

Reliable Data Collection

Seamless integration delivers accurate data to support better trial outcomes.

Join Our Team

At Replior, we bring together clinical researchers, software engineers, and data specialists to build better ways to collect clinical trial data. We are a team driven by problem-solving, innovation, and close collaboration with our customers.
We do not have open positions right now, but we are always open to meeting people who are passionate about improving clinical trials. Send your CV and a short introduction to careers@replior.com.